Correlation Between Wuhan General and Cannara Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Wuhan General and Cannara Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Wuhan General and Cannara Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Wuhan General Gr and Cannara Biotech, you can compare the effects of market volatilities on Wuhan General and Cannara Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Wuhan General with a short position of Cannara Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Wuhan General and Cannara Biotech.

Diversification Opportunities for Wuhan General and Cannara Biotech

0.63
  Correlation Coefficient

Poor diversification

The 3 months correlation between Wuhan and Cannara is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Wuhan General Gr and Cannara Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cannara Biotech and Wuhan General is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Wuhan General Gr are associated (or correlated) with Cannara Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cannara Biotech has no effect on the direction of Wuhan General i.e., Wuhan General and Cannara Biotech go up and down completely randomly.

Pair Corralation between Wuhan General and Cannara Biotech

If you would invest  51.00  in Cannara Biotech on August 28, 2024 and sell it today you would earn a total of  1.00  from holding Cannara Biotech or generate 1.96% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy4.76%
ValuesDaily Returns

Wuhan General Gr  vs.  Cannara Biotech

 Performance 
       Timeline  
Wuhan General Gr 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Wuhan General Gr has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical indicators, Wuhan General is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.
Cannara Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cannara Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable technical and fundamental indicators, Cannara Biotech is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Wuhan General and Cannara Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Wuhan General and Cannara Biotech

The main advantage of trading using opposite Wuhan General and Cannara Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Wuhan General position performs unexpectedly, Cannara Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannara Biotech will offset losses from the drop in Cannara Biotech's long position.
The idea behind Wuhan General Gr and Cannara Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Bonds Directory
Find actively traded corporate debentures issued by US companies
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.